AnproTech
AnproTech, Inc., founded in 2004 and located in Milpitas, CA, is a contract research organization specializing in antibody and protein engineering, and structural biology. They provide comprehensive biological and immunological solutions to academic researchers and biopharmaceutical companies, aiming to accelerate drug development pipelines. AnproTech offers a wide range of services including antibody discovery (hybridoma, single B cell cloning, phage display), antibody engineering (bi-specific antibodies, humanization, affinity maturation), developability assessment, CMC optimization, biological production (reagent, GLP, GMP), and preclinical studies. Their synthetic full human antibody library (SFHAL) is a key product, developed using bioinformatics and machine learning, offering optimized human antibody V domain genes for therapeutic antibody discovery. AnproTech has a track record of over 200 antibody discovery and engineering projects, emphasizing quality results and potential patient benefit.
AnproTech
AnproTech, Inc., founded in 2004 and located in Milpitas, CA, is a contract research organization specializing in antibody and protein engineering, and structural biology. They provide comprehensive biological and immunological solutions to academic researchers and biopharmaceutical companies, aiming to accelerate drug development pipelines. AnproTech offers a wide range of services including antibody discovery (hybridoma, single B cell cloning, phage display), antibody engineering (bi-specific antibodies, humanization, affinity maturation), developability assessment, CMC optimization, biological production (reagent, GLP, GMP), and preclinical studies. Their synthetic full human antibody library (SFHAL) is a key product, developed using bioinformatics and machine learning, offering optimized human antibody V domain genes for therapeutic antibody discovery. AnproTech has a track record of over 200 antibody discovery and engineering projects, emphasizing quality results and potential patient benefit.